Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

825 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Polymorphism of the CYP1A1 and glutathione-S-transferase gene in Korean lung cancer patients.
Hong YS, Chang JH, Kwon OJ, Ham YA, Choi JH. Hong YS, et al. Exp Mol Med. 1998 Dec 31;30(4):192-8. doi: 10.1038/emm.1998.28. Exp Mol Med. 1998. PMID: 9894148
Effects of buthionine sulfoximine treatment on cellular glutathione levels and cytotoxicities of cisplatin, carboplatin and radiation in human stomach and ovarian cancer cell lines.
Lee KS, Kim HK, Moon HS, Hong YS, Kang JH, Kim DJ, Park JG. Lee KS, et al. Among authors: hong ys. Korean J Intern Med. 1992 Jul;7(2):111-7. doi: 10.3904/kjim.1992.7.2.111. Korean J Intern Med. 1992. PMID: 1306072 Free PMC article.
The impact of HLA-DRB1*0405 on disease severity in Korean patients with seropositive rheumatoid arthritis.
Kim HY, Min JK, Yang HI, Park SH, Hong YS, Jee WH, Lee SH, Cho CS, Kim TG, Han H. Kim HY, et al. Among authors: hong ys. Br J Rheumatol. 1997 Apr;36(4):440-3. doi: 10.1093/rheumatology/36.4.440. Br J Rheumatol. 1997. PMID: 9159536
Decreased tumour necrosis factor-beta production in TNFB*2 homozygote: an important predisposing factor of lupus nephritis in Koreans.
Lee SH, Park SH, Min JK, Kim SI, Yoo WH, Hong YS, Park JH, Cho CS, Kim TG, Han H, Kim HY. Lee SH, et al. Among authors: hong ys. Lupus. 1997;6(7):603-9. doi: 10.1177/096120339700600708. Lupus. 1997. PMID: 9302664
Quality of life (QOL) assessment of MIP (mitomycin, ifosfamide and cisplatin) chemotherapy in advanced non-small cell lung cancers (NSCLC).
Han JY, Kim HK, Choi BG, Moon H, Hong YS, Lee KS. Han JY, et al. Among authors: hong ys. Jpn J Clin Oncol. 1998 Dec;28(12):749-53. doi: 10.1093/jjco/28.12.749. Jpn J Clin Oncol. 1998. PMID: 9879293 Clinical Trial.
A phase II study of a daily x4 schedule of vinorelbine plus cisplatin for advanced non-small cell lung cancer.
Han JY, Kim KW, Kim JA, Kang JH, Jin JY, Hong YS, Park SY, Song JS, Park JW, Kim HK, Lee KS, Choi BG. Han JY, et al. Among authors: hong ys. Jpn J Clin Oncol. 2000 Oct;30(10):435-9. doi: 10.1093/jjco/hyd118. Jpn J Clin Oncol. 2000. PMID: 11185889 Clinical Trial.
Analysis of p53 and BAX mutations, loss of heterozygosity, p53 and BCL2 expression and apoptosis in basal cell carcinoma in Korean patients.
Cho S, Hahm JH, Hong YS. Cho S, et al. Among authors: hong ys. Br J Dermatol. 2001 Apr;144(4):841-8. doi: 10.1046/j.1365-2133.2001.04142.x. Br J Dermatol. 2001. PMID: 11298546
Identification of HLA-A*11 variant (A*1107) in the Korean population.
Pyo CW, Choi HB, Han H, Hong YS, Kim TG. Pyo CW, et al. Among authors: hong ys. Tissue Antigens. 2001 Sep;58(3):190-2. doi: 10.1034/j.1399-0039.2001.580309.x. Tissue Antigens. 2001. PMID: 11703829
Three-week schedule of irinotecan plus cisplatin in patients with previously untreated extensive-stage small-cell lung cancer.
Hong YS, Lee HR, Park S, Lee SC, Hwang IG, Park BB, Lee J, Ahn JS, Ahn MJ, Lim HY, Park K. Hong YS, et al. Br J Cancer. 2006 Dec 18;95(12):1648-52. doi: 10.1038/sj.bjc.6603500. Epub 2006 Nov 28. Br J Cancer. 2006. PMID: 17133266 Free PMC article. Clinical Trial.
Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity.
Kim KP, Jang G, Hong YS, Lim HS, Bae KS, Kim HS, Lee SS, Shin JG, Lee JL, Ryu MH, Chang HM, Kang YK, Kim TW. Kim KP, et al. Among authors: hong ys. Br J Cancer. 2011 Feb 15;104(4):605-12. doi: 10.1038/bjc.2011.17. Br J Cancer. 2011. PMID: 21326246 Free PMC article. Clinical Trial.
825 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback